1. In this retrospective cohort study, clinical outcomes and recurrence rates of mild to moderate Clostridium difficile infection (CDI) were ...
1. Bezlotoxumab therapy associated with significantly lower rate of recurrent C. difficile infection compared to placebo. 2. Actoxumab not efficacious ...
1. Screening for and isolating carriers of Clostridium difficile at admission to hospital was associated with lower rates of healthcare-associated ...
1. Chemical screening showed that ebselem, a small molecule currently in clinical trials for unrelated usclostres, inhibited the cysteine ...
1. In this study, spores of non-toxigenic Clostridium difficile (C. difficile; M3 strain) administered for prevention of recurrent C. difficile ...
1. Clostridium difficile (C. difficile) infection is often seen in hospitalized patients who take antibiotics. 2. Antibiotic prescribing patterns on ...
1. A frozen fecal microbiotia transplant was effective in resolving diarrhea in individuals with refractory or recurrent Clostridium difficile infection. ...
1. Treating recurrent C. difficile infection with infusion of donor feces resulted in significantly higher cure rates than treating with ...
1. Fidaxomicin is non-inferior to vancomycin in achieving clinical cure of C. difficile infection 2. Fidaxomicin therapy significantly reduces the ...
Image: PD 1. The administration of microbial preparations to inpatients at risk of developing antibiotic-associated diarrhea (AAD) or Clostridium difficile ...
